Literature DB >> 2501767

TRH analog MK-771 reverses neurochemical and learning deficits in medial septal-lesioned rats.

A Horita1, M A Carino, J Zabawska, H Lai.   

Abstract

Microinjection of ibotenic acid into medial septum of rats decreased choline acetyltransferase (CAT) and high-affinity choline uptake (HACU) activities in hippocampus and retarded the learning of a spatial memory task in the radial-arm maze. Administration of MK-771, a stable TRH analog, to such animals restored HACU activity in hippocampus to normal levels. Daily treatment of rats with MK-771 prior to maze running also restored the animals' learning ability. MK-771 did not enhance hippocampal HACU activity or maze performance in sham-lesioned rats. These results suggest that MK-771 reversed the ibotenic acid-induced memory deficit by restoring septohippocampal cholinergic function. MK-771 and other TRH analogs may represent novel agents for improving memory deficits produced by cholinergic insufficiency in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2501767     DOI: 10.1016/0196-9781(89)90087-9

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  3 in total

1.  Effect of a thyrotrophin-releasing hormone analogue, RX77368, on AMPA-induced septal-hippocampal lesioned rats in an operant delayed non-matching to position test.

Authors:  T M Ballard; A J Hunter; G W Bennett
Journal:  Psychopharmacology (Berl)       Date:  1996-10       Impact factor: 4.530

2.  Effect of thyrotropin releasing hormone (TRH) on acetylcholine release from different brain areas investigated by microdialysis.

Authors:  M G Giovannini; F Casamenti; A Nistri; F Paoli; G Pepeu
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

3.  Analogs of thyrotropin-releasing hormone (TRH): receptor affinities in brains, spinal cords, and pituitaries of different species.

Authors:  N A Sharif; Z P To; R L Whiting
Journal:  Neurochem Res       Date:  1991-02       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.